@article{article, title  = {{UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{https://doi.org/10.1093/oncolo/oyaf220 }},

 year = {{2025}},

 month = {{10}},

 author = {{Hussain S and Carr A and Crabb SJ and Dodhia V and Fearfield L and Malik JM and Lapuente M and Lau D and Petruskin H and Sarwar N and Smith NJ et al}},

 doi = {{10.1093/oncolo/oyaf220}},

 volume = {{30}},

 journal = {{The Oncologist}},

 issue = {{10}},

 note = {{Accessed on 2025/11/15}}}